@vvampastompai
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States Android App
Account-level information from X, not a live location or the device used for a specific post.
𝖍𝖔𝖓𝖞 𝖘𝖔𝖞𝖙 𝖖𝖚𝖎 𝖒𝖆𝖑 𝖕𝖊𝖓𝖈𝖊 🪱 ribeli kontraŭ tiranoj estas obei al dio 🌻
o.m.o. ៚
Joined January 2025
- Tweets2.3K
- Following599
- Followers81
- Likes10K
Pinned Tweet
$RDW x Mike Oldfield "Hergest Ridge"
1 of (if not 1st) vinyl i ever thrifted, has an aura/confidence/anxious-curious meandering (if Restless Leg Syndrome was a dear friend having coffee w u at 1am)
matched perhaps only by Aloha "Here Comes Everyone," but that's a diff story...
On September 22, the Coronagraph Instrument on NASA's Nancy Grace Roman Space Telescope opened its eyes to cosmic light for the first time, which is commanded from Caltech's IPAC.
caltech.edu/about/news/nasas…
vvampa ⚶ retweeted
Me? With my claws and teeth I will will defend art and artists as essential to any version of a beautiful livable world.
a-rabbitsfoot.com/editorial/…
vvampa ⚶ retweeted
I genuinely don't get Anthropic. It seems like every other day they're loudly puzzling over the ethics of a soul in a box - while building the box, claiming that it has a soul in it, and selling access to said box to for $20 a pop.
Like, dudes, these are incompatible positions.
vvampa ⚶ retweeted
Excited to release our first @deleon_bio blog post (link in thread)!
Over the past year, Deleon Bio has reinvented how omics can be done (...daily-omics...daily-on...deleon...).
We decided to stop keeping it to ourselves.
Our advancements in low-cost sampling have allowed, for the first time, a scalable platform at a time resolution that will actually matter to people, every single day.
Thousands of daily samples from volunteers gave us the backbone we needed to benchmark our capabilities.
All our breakthroughs these past 12 months have come from hardcore science, engineering, and AI research.
Helping consumers is still a step along that path, and the thing that makes all this worth it in the end. But we have to get there faster. That's why we’re doubling down on data collection and scaling our models up!
Over the next couple weeks we will be releasing more posts about our progress on AI models and our benchmarks.
vvampa ⚶ retweeted
Two for two now since Fed’s Sep rate hike…. So inflation is not as hot, and neither is labor market, nor wages.
This is just 2 weeks after the FOMC meeting.
vvampa ⚶ retweeted
How ARPA-H is planning to cut clinical trial times from 10+ years to <4 years:
1. 'Phaseless' clinical trials - move towards replacing phase 1 → 2 → 3 with adaptive trials that can cut failed drugs (or advance good ones) faster.
2. Simulate trial outcomes before starting, with digital twins - to reduce reliance on large control groups.
3. AI agents for trial operations.
4. Turn ordinary hospitals into reusable clinical trial sites, and gets AIs to flag eligible trials to doctors and patients.
ARPA-H Advancing Clinical Trials Announcement nitter.cf/i/broadcasts/1vKpPNOwV…
i like when the authors barely fit on my laptop screen
biorxiv.org/content/10.64898…
vvampa ⚶ retweeted
AI models alone gave designs where ~20% beat the starting enzyme. Adding physics-based modeling raised that to ~55%.
In a second program, AI + physics + data reached ~73%, vs ~25% for AI alone.
vvampa ⚶ retweeted
AI and physics models design the enzymes. Robots build and test them.
Our new white paper explains how we engineer enzymes, with results from programs for clients and U.S. Government partners:
ginkgo.bio/press-releases/ne…
one of the most fun collabs of the year
up there with:
- Ginkgo x Twist x Lilly x Benchling
- United Therapeutics x Varda Space
- Arteris x Arm
- Ginkgo x Caltech
- Nous Research x basically everyone
Reference-Free Passive Radar Using Starlink Signals of Opportunity
Vladimir Volman - NASA Glenn Research Center (Retired)
mdpi.com/2673-4001/7/5/119
vvampa ⚶ retweeted
Nobody is "losing the end" of the bond curve. The yield curve is flat, not steep.
Rather, some people are losing the argument for what interest rates should be in this environment and the market is adjusting accordingly.
Nothing stops this train.
Clinical trials still move like it’s 1995.
A decade of waiting, $1–2 billion spent, and a 90%+ failure rate on a clunky, fragmented system.
ARPA-H’s SURPASS program is rethinking the entire clinical trial model.
Adaptive platforms, predictive models, real-time analysis, and AI will make trials faster and cheaper so treatments reach patients years earlier.
Ready to stop waiting? Learn more about SURPASS ➡️arpa-h.gov/explore-funding/p…
vvampa ⚶ retweeted
Anthropic posted a report on free chinese open model GLM-5.3. It reads like a product sheet. GLM-5.3 is very strong in cybersecurity tasks. Builds Chrome exploits nearly as well as Claude Mythos Preview (12% vs 14%), the model Anthropic considered too dangerous to release. Mythos for vetted users, GLM-5.3 free for all. Turning a public Chrome bug into a working exploit cost $20.40. Removing the safety constraints from GLM-5.3 costs $1200. Anthropic's conclusion is that defenders need AI models as good as the attackers', and Anthropic sells some. anthropic.com/research/glm-5…
anthropic: banned by govt for being supply chain risk
openai: anduril guy gives gameboys to everyone at dev event
vvampa ⚶ retweeted
One of the worst forms of brainrot AI has cultivated is pessimism about basic research, ie the idea that important work can only happen inside a frontier/neo lab and only with 10k+ GPUs, so the rest should not even bother. What a bleak way to think about science. And it's false.